LOS ANGELES, Jan. 15 /PRNewswire/ -- The Multiple Myeloma Research Foundation (MMRF), in collaboration with Lymphoma Research Foundation (LRF) and Medical Education Collaborative, will hold its Institutional Insights symposium, “Novel Therapeutic Approaches in the Treatment of Multiple Myeloma and Lymphoma,” on Friday, February 6, 2004 at the St. Regis Hotel, in Los Angeles, California.
Institutional Insights is a unique program pioneered by the MMRF with leading experts in the field of myeloma and lymphoma presenting the most up-to-date treatment information to local oncologists, nurses, researchers, patients and their families. The symposia are interactive half-day programs that offer CME and CE credit for clinicians and nurses.
The Course Director and Myeloma Program Chair is James Berenson, MD, Institute for Myeloma & Bone Cancer Research; and Christos Emmanouilides, MD, PhD, from UCLA School of Medicine, is the Lymphoma Program Chair. Ground- breaking research on advances in understanding and treating myeloma and lymphoma will be presented by the following experts: Steven Coutre, MD, Stanford University School of Medicine; Stephen Forman, MD, City of Hope National Medical Center; Randy D. Gascoyne, MD, British Columbia Cancer Agency; David Siegel, MD, Hackensack University Medical Center; Edward Stadtmauer, MD, University of Pennsylvania School of Medicine; and John M. Timmerman, MD, UCLA School of Medicine.
The esteemed panel will discuss the latest therapies for multiple myeloma and lymphoma, including: high-dose chemotherapy and stem-cell transplantation, antibody and vaccine therapy, bone disease management and, novel new agents, such as CC-5013, thalidomide, and VELCADE (bortezomib, formerly known as PS-341). On Friday, February 6th, the professional CME/CE program will start at 8:00 AM to 12:30 PM (continental breakfast and registration open at 7:30 AM). The same program is offered separately and free-of charge for patients, caregivers and family at 3:00 - 7:00 PM (a boxed dinner is included).
For more information please contact Sara Nichols, Program Coordinator, at 203-972-1250 or nicholss@themmrf.org. Registration information available at: http://www.multiplemyeloma.org/events.
Celgene, CTI, Genitope Corporation, Novartis, Millennium and Supergen are sponsors of this program.
About the MMRF
The Multiple Myeloma Research Foundation (MMRF) is the world’s number one private funder of multiple myeloma research. Founded in 1998, the MMRF is a non-profit foundation driven by a single purpose: to accelerate the search for a cure for multiple myeloma. To date, the MMRF has committed over $15 million towards funding the leading researchers worldwide. As a volunteer-driven organization, 93 percent of funds raised by the MMRF are channeled directly into supporting pivotal multiple myeloma research and related programming. To learn more about the MMRF, call 203-972-1250 or visit http://www.multiplemyeloma.org/.
About the LRF
The Lymphoma Research Foundation (LRF) is the nation’s largest voluntary health organization devoted exclusively to funding research to cure all lymphomas and providing patients and healthcare professionals with critical information on the disease. LRF was formed in November 2001 by the merger of the Cure for Lymphoma Foundation (CFL) and the Lymphoma Research Foundation of America (LRFA). As of 2004, LRF will have committed over $18 Million to fund lymphoma-related research projects around the world. For more information on LRF call 800-500-9976, or visit: http://www.lymphoma.org/
The Multiple Myeloma Research Foundation
CONTACT: Sara Nichols of The Multiple Myeloma Research Foundation,+1-203-652-0206, nicholss@themmrf.org
